168 related articles for article (PubMed ID: 33999892)
1. Nutritional Optic Neuropathy From Chronic Omeprazole Use.
Rehmani A; Mehta I; Siu NY; Smith E
J Neuroophthalmol; 2021 Jun; 41(2):e169-e171. PubMed ID: 33999892
[No Abstract] [Full Text] [Related]
2. Omeprazole-induced cough in a patient with gastroesophageal reflux disease.
Reiche I; Tröger U; Martens-Lobenhoffer J; Kandulski A; Neumann H; Malfertheiner P; Bode-Böger SM
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):880-2. PubMed ID: 19801940
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Anterior and Intermediate Uveitis Associated With Omeprazole.
Shifera AS
Ann Pharmacother; 2020 Apr; 54(4):397-399. PubMed ID: 31744307
[No Abstract] [Full Text] [Related]
4. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
5. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
[TBL] [Abstract][Full Text] [Related]
6. Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.
Waldum HL; Hauso Ø; Fossmark R
Aliment Pharmacol Ther; 2015 Aug; 42(3):389. PubMed ID: 26147114
[No Abstract] [Full Text] [Related]
7. An Interesting Case of "Refractory" Hypomagnesemia.
Koh ZY; Lim SWM; Lim WS
J Am Med Dir Assoc; 2017 Jul; 18(7):632-633. PubMed ID: 28549719
[No Abstract] [Full Text] [Related]
8. Omeprazole in oesophageal reflux disease.
Dawson R; Manson JM
Lancet; 2000 Nov; 356(9243):1770-1. PubMed ID: 11095286
[No Abstract] [Full Text] [Related]
9. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.
Ruscin JM; Page RL; Valuck RJ
Ann Pharmacother; 2002 May; 36(5):812-6. PubMed ID: 11978157
[TBL] [Abstract][Full Text] [Related]
10. Situs inverses of blind spot on Humphrey visual fields: Can we trust what we see?
Mansoori T
Indian J Ophthalmol; 2020 Mar; 68(3):542-543. PubMed ID: 32057031
[No Abstract] [Full Text] [Related]
11. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
[TBL] [Abstract][Full Text] [Related]
12. Agranulocytosis induced by proton pump inhibitors.
Dury S; Nardi J; Gozalo C; Lebargy F; Deslee G
J Clin Gastroenterol; 2012; 46(10):859. PubMed ID: 22240865
[TBL] [Abstract][Full Text] [Related]
13. Biological plausibility between proton pump inhibitory therapy and hip fracture: hyperhomocysteinemia can be the link.
Roblin X; Phelip JM
Am J Gastroenterol; 2009 Apr; 104(4):1052. PubMed ID: 19240711
[No Abstract] [Full Text] [Related]
14. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.
Attwood SE; Ell C; Galmiche JP; Fiocca R; Hatlebakk JG; Hasselgren B; Långström G; Jahreskog M; Eklund S; Lind T; Lundell L
Aliment Pharmacol Ther; 2015 Jun; 41(11):1162-74. PubMed ID: 25858519
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.
Qi Q; Wang R; Liu L; Zhao F; Wang S
Int J Clin Pharmacol Ther; 2015 Oct; 53(10):803-10. PubMed ID: 26329348
[TBL] [Abstract][Full Text] [Related]
16. Silent acid reflux and asthma control.
Asano K; Suzuki H
N Engl J Med; 2009 Apr; 360(15):1551-3. PubMed ID: 19357411
[No Abstract] [Full Text] [Related]
17. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.
Pouchain D; Bigard MA; Liard F; Childs M; Decaudin A; McVey D
BMC Gastroenterol; 2012 Feb; 12():18. PubMed ID: 22361121
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid-induced toxic optic neuropathy.
Teus MA; Teruel JL; Pascual J; Martin-Escobar E
Am J Ophthalmol; 1991 Nov; 112(5):605-6. PubMed ID: 1951609
[No Abstract] [Full Text] [Related]
19. [Efficacy and safety of OTC omeprazole].
Labenz J; Willmer C
MMW Fortschr Med; 2012 Dec; 154 Suppl 4():110-4. PubMed ID: 23326929
[TBL] [Abstract][Full Text] [Related]
20. Visual function in recovered ethambutol optic neuropathy.
Woung LC; Jou JR; Liaw SL
J Ocul Pharmacol Ther; 1995; 11(3):411-9. PubMed ID: 8590273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
